The West Midlands Combined Authority has selected nine businesses to receive £1.3 million in research and development funding for new products, production methods and industrial technologies. The first awards form part of the West Midlands Investment Zone Supply Chain Transition programme and will be accompanied by £1.4 million in investment from the recipients themselves. The companies span precision manufacturing, specialist materials, recycling, sensors and emerging low-carbon products rather than a single branch of engineering.
The grants are drawn from a £6 million research and development fund within the Investment Zone Supply Chain Transition programme. Taken together, the public awards and £1.4 million contributed by the recipients amount to £2.7 million for the nine development projects. Neither that funding commitment nor selection for support represents an increase in production capacity that has already been achieved. The participating businesses must still complete development work before individual products or processes can be transferred into routine manufacture.
The recipients are Birmingham-based 4T2 Sensors, Brandauer & Co and Tooling 2000; Wolverhampton’s SymbioTex; Walsall-based Gainsborough Healthcare Group; Darvick of Brierley Hill; European Materials Recycling Group, which operates across the region; Plant Carbon of Warwick; and Tecman Speciality Materials of Leamington. Their selection brings together established engineering suppliers and younger businesses developing alternatives to conventional materials. Individual grant allocations and project milestones were not disclosed in the announcement.
SymbioTex is developing seaweed-derived materials intended to replace certain single-use plastics, including an anti-static packaging product. The company was founded by University of Wolverhampton graduates Olivia Simpson and Dr Mattia Parati and is seeking uses in more demanding industrial supply chains. Anti-static packaging must limit the accumulation or discharge of electrical charge around sensitive contents, while also meeting handling and production requirements. The grant supports the development work; it does not establish that the seaweed-based formulation has already passed every customer qualification test.
Precision stamping specialist Brandauer is included among the nine companies. It is working with Warwick Manufacturing Group on electric motor lamination production, an activity involving the repeatable manufacture and joining of thin electrical steel sheets. Brandauer’s £199,500 project was identified separately earlier in October; the regional allocation places that same undertaking within the larger grant programme, rather than establishing a second award. The combined funding total should therefore not be read as additional money on top of every previously disclosed recipient grant.
The Investment Zone programme follows the West Midlands Reindustrialisation Blueprint introduced earlier in October. Early research funding can cover experiments and process development before a business has enough evidence to invest in tooling, production controls and customer qualification. SymbioTex, for example, will need to establish both anti-static performance and stable processing of its seaweed-based material if the proposed packaging is to enter electronics supply chains. Comparable technical and commercial requirements will differ across the other eight businesses.
Alongside the grants, the Supply Chain Transition programme offers practical business development and growth support to more than 200 manufacturers. Its activities include identifying new industrial markets, access to potential customers, and management training. The programme is being delivered by the combined authority with Supply Smarter West Midlands, a partnership involving C&W Business Solutions, the Manufacturing Technology Centre, Warwick Manufacturing Group and three regional universities. The authority says £12.5 million in government funding has been secured for the wider initiative.
Moving into automotive electrification, aerospace or medical technology often requires suppliers to develop different evidence from that accepted by existing customers. Production drawings alone may not demonstrate control of material properties, traceability, inspection or repeatable delivery. Access to specialist engineering support and potential customers can help determine whether an early process is capable of meeting those requirements before substantial factory investment. No customer qualification decisions or resulting production orders for this group of nine projects have been disclosed.
More than 70 regional businesses have already received help to identify new markets and engage with prospective original equipment manufacturer customers through the wider transition programme. The nine grants add funded research projects to that support. Their subsequent performance will depend on the technical evidence generated, any further industrial investment and customers’ willingness to order at viable prices. The £1.3 million awards and £1.4 million matching commitments are established; manufacturing employment, output and productivity gains remain objectives rather than delivered results.
